|
2022 Journal Article Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019Laupland, Kevin B., Stewart, Adam G., Edwards, Felicity, Harris, Patrick, Heney, Claire, George, Narelle, Coulter, Sonali and Paterson, David L. (2022). Pasteurella species bloodstream infections in Queensland, Australia, 2000–2019. European Journal of Clinical Microbiology and Infectious Diseases, 41 (4), 609-614. doi: 10.1007/s10096-022-04411-w |
|
2022 Journal Article Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritisSimos, Peter and Stewart, Adam G. (2022). Sexually acquired reactive arthritis secondary to macrolide‐resistant Mycoplasma genitalium urethritis. Internal Medicine Journal, 52 (2), 332-333. doi: 10.1111/imj.15684 |
|
2021 Journal Article Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trialStewart, Adam G, Henderson, Andrew, Bauer, Michelle J, Paterson, David L and Harris, Patrick N A (2021). Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial. JAC-Antimicrobial Resistance, 4 (1) dlab192, dlab192. doi: 10.1093/jacamr/dlab192 |
|
2021 Journal Article A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic reviewHenderson, Andrew, Bursle, Evan, Stewart, Adam, Harris, Patrick N. A., Paterson, David, Chatfield, Mark D., Paul, Mical, Dickstein, Yaakov, Rodriguez-Baño, Jesus, Turnidge, John D. and Kahlmeter, Gunnar (2021). A systematic review of antimicrobial susceptibility testing as a tool in clinical trials assessing antimicrobials against infections due to Gram negative pathogens. Intended category: systematic review. Clinical Microbiology and Infection, 27 (12), 1746-1753. doi: 10.1016/j.cmi.2021.03.019 |
|
2021 Journal Article Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trialStewart, Adam G., Harris, Patrick N. A., Chatfield, Mark D., Littleford, Roberta and Paterson, David L. (2021). Ceftolozane-tazobactam versus meropenem for definitive treatment of bloodstream infection due to extended-spectrum beta-lactamase (ESBL) and AmpC-producing Enterobacterales (“MERINO-3”): study protocol for a multicentre, open-label randomised non-inferiority trial. Trials, 22 (1) 301, 301. doi: 10.1186/s13063-021-05206-8 |
|
2021 Journal Article An update on the laboratory diagnosis of Rickettsia spp. infectionStewart, Adam G. and Stewart, Alexandra G. A. (2021). An update on the laboratory diagnosis of Rickettsia spp. infection. Pathogens, 10 (10) 1319, 1319. doi: 10.3390/pathogens10101319 |
|
2021 Journal Article An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ responseIsler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2021). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa–—authors’ response. Journal of Antimicrobial Chemotherapy, 76 (12), 3327-3328. doi: 10.1093/jac/dkab366 |
|
2021 Journal Article Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathyStewart, Adam G., Sinclair, Holly, Chapman, Paul, Baboolal, Keshwar, Barber, Bridget E. and Townsend, Shane (2021). Cryptococcus neoformans infection as a cause of severe hyperammonaemia and encephalopathy. Internal Medicine Journal, 51 (10), 1750-1751. doi: 10.1111/imj.15516 |
|
2021 Journal Article Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2)Stewart, Adam G., Paterson, David L., Young, Barnaby, Lye, David C, Davis, Joshua S., Schneider, Kellie, Yilmaz, Mesut, Dinleyici, Rumeysa, Runnegar, Naomi, Henderson, Andrew, Archuleta, Sophia, Kalimuddin, Shirin, Forde, Brian M., Chatfield, Mark D., Bauer, Michelle J., Lipman, Jeffrey, Harris-Brown, Tiffany, Harris, Patrick N. A. and for the MERINO Trial Investigators and the Australasian Society for Infectious Disease Clinical Research Network (ASID-CRN) (2021). Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections caused by AmpC beta-lactamase producing Enterobacter spp., Citrobacter freundii, Morganella morganii, Providencia spp., or Serratia marcescens: a pilot multi-center randomized controlled trial (MERINO-2). Open Forum Infectious Diseases, 8 (8) ofab387, ofab387. doi: 10.1093/ofid/ofab387 |
|
2021 Journal Article Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous diseaseStewart, Adam G., Baidya, Shoma, Daly, James and Scott, Ashleigh P. (2021). Prolonged granulocyte transfusions sourced from buffy coats used to treat Aspergillus spp. infection in chronic granulomatous disease. Pathology, 54 (3), 358-361. doi: 10.1016/j.pathol.2021.05.098 |
|
2021 Journal Article In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO TrialStewart, Adam G., Cottrell, Kyra, Henderson, Andrew, Vemuri, Kanthi, Bauer, Michelle J., Paterson, David L. and Harris, Patrick N. A. (2021). In vitro activity of Cefotetan against ESBL-producing Escherichia coli and Klebsiella pneumoniae bloodstream isolates from the MERINO Trial. Microbiology Spectrum, 9 (1) e00226-21, 1-6. doi: 10.1128/spectrum.00226-21 |
|
2021 Journal Article New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of carePeri, Anna Maria, Stewart, Adam, Hume, Anna, Irwin, Adam and Harris, Patrick N A (2021). New microbiological techniques for the diagnosis of bacterial infections and sepsis in ICU including point of care. Current Infectious Disease Reports, 23 (8) 12, 12. doi: 10.1007/s11908-021-00755-0 |
|
2021 Journal Article Completing the picture - capturing the resistome in antibiotic clinical trialsStewart, Adam G., Satlin, Michael J., Schlebusch, Sanmarié, Isler, Burcu, Forde, Brian M., Paterson, David L. and Harris, Patrick N. A. (2021). Completing the picture - capturing the resistome in antibiotic clinical trials. Clinical Infectious Diseases, 72 (12), e1122-e1129. doi: 10.1093/cid/ciaa1877 |
|
2021 Journal Article Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantationChung, Joseph, McCarthy, Kate L., Redmond, Andrew, Butler, Jason, Scott, Ashleigh P. and Stewart, Adam G. (2021). Listeria monocytogenes brain abscess as a late complication of allogeneic haemopoietic stem cell transplantation. Internal Medicine Journal, 51 (6), 1005-1006. doi: 10.1111/imj.15356 |
|
2021 Journal Article Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, AustraliaStewart, A. G., Price, E. P., Schabacker, K., Birikmen, M., Harris, P. N. A., Choong, K., Subedi, S. and Sarovich, D. S. (2021). Molecular epidemiology of third-generation cephalosporin-resistant Enterobacteriaceae in Southeast Queensland, Australia. Antimicrobial Agents and Chemotherapy, 65 (6) e00130-21, 1-13. doi: 10.1128/AAC.00130-21 |
|
2021 Journal Article Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosisStewart, Adam G. and Lane, Steven (2021). Just as good but better tolerated: posaconazole as first-line therapy for invasive aspergillosis. The Hematologist, 18 (3). |
|
2021 Journal Article How urgent is the need for new antifungals?Stewart, Adam G. and Paterson, David L. (2021). How urgent is the need for new antifungals?. Expert Opinion on Pharmacotherapy, 22 (14), 1-14. doi: 10.1080/14656566.2021.1935868 |
|
2021 Journal Article Infectious complications of CAR T-cell therapy: a clinical updateStewart, Adam G. and Henden, Andrea S. (2021). Infectious complications of CAR T-cell therapy: a clinical update. Therapeutic Advances in Infectious Disease, 8 204993612110367, 1-11. doi: 10.1177/20499361211036773 |
|
2020 Journal Article An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosaIsler, Burcu, Harris, Patrick, Stewart, Adam G. and Paterson, David L. (2020). An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa. The Journal of Antimicrobial Chemotherapy, 76 (3), 550-560. doi: 10.1093/jac/dkaa511 |
|
2020 Journal Article Achromobacter infections and treatment optionsIsler, Burcu, Kidd, Timothy J., Stewart, Adam G., Harris, Patrick and Paterson, David L. (2020). Achromobacter infections and treatment options. Antimicrobial Agents and Chemotherapy, 64 (11) e01025, 1-16. doi: 10.1128/aac.01025-20 |
